Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-04-11)Premium Content

Nektar Therapeutics (NKTR)

2014-04-24@12:36:27 ET
Nektar Therapeutics (NKTR) Showing Neutral Technicals With Resistance At $12.61 (FBM)

2014-04-24@08:25:55 ET
Bottom 5 Companies in the Pharmaceuticals Industry with the Lowest Relative Performance (AUXL, VVUS, AKRX, NKTR, DEPO) (F70)

2014-04-23@09:49:37 ET
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Allergan (AGN, NKTR, VRX, DEPO, JAZZ) (F70)

2014-04-23@08:49:48 ET
Nektar Therapeutics (NKTR) Trading Near $13.01 Resistance Level (FBM)

2014-04-22@14:22:45 ET
Trading Higher on Heavy Volume are Shares of Nektar Therapeutics on 1.3x Above-Average Volume (NKTR) (F82)

2014-04-22@12:04:52 ET
Shares of Nektar Therapeutics Receive a Boost, Up 10.8% (F77)

2014-04-16@13:24:56 ET
Nektar Therapeutics (NKTR) Showing Bearish Technicals With Support At $9.82 (FBM)

2014-04-16@08:08:22 ET
Relatively Good Performance Detected in Shares of Allergan in the Pharmaceuticals Industry (AGN, NKTR, VRX, JNJ, JAZZ) (F70)

2014-04-16@00:39:15 ET
8-K: NEKTAR THERAPEUTICS (EDK)

2014-04-15@08:36:15 ET
Nektar Therapeutics (NKTR) Trading Near $11.32 Resistance Level (FBM)

2014-04-14@14:23:13 ET
Buyers Accumulate Shares of Nektar Therapeutics, Up 2.7% (F77)

2014-04-14@08:33:08 ET
Flamel Technologies has Relatively Underperformed its Peers in the Pharmaceuticals Industry (FLML, AUXL, NBS, NKTR, VRX) (F70)

2014-04-14@05:19:20 ET
Nektar announces positive preclinical data from breast and colon cancer studies (DTM)

2014-04-11@08:31:21 ET
Short-term Underperformance Detected in Shares of Depomed in the Pharmaceuticals Industry (DEPO, NKTR, JAZZ, AUXL, SLXP) (F70)